首页> 外文期刊>外科学(英文) >Risk Factors of Post-Operative Extracorporeal Membrane Oxygenation Support after Lung Transplantation: A Retrospective Analysis
【24h】

Risk Factors of Post-Operative Extracorporeal Membrane Oxygenation Support after Lung Transplantation: A Retrospective Analysis

机译:肺移植术后术后体外膜氧合支持的危险因素:回顾性分析

获取原文
获取原文并翻译 | 示例
       

摘要

Background: Extracorporeal membrane oxygenation (ECMO) is an effective adjuvant therapy for cardiopulmonary support during the period of lung transplantation (LTx). However, factors associated with the application of ECMO after LTx remain controversial. The purpose of this study is to clarify the risk factors of post-operative ECMO support and to evaluate the outcomes. Methods: It was a hospital, single-center, retrospective study. 266 patients underwent LTx supported by ECMO were included. According to whether or not the patients received continourly ECMO support after the surgery, the enrolled patients were further divided into intra-operative ECMO group (group I, 105 cases) and post-operative ECMO group (group P, 161 cases). The peri-operative data of the donors and recipients were collected. The independent risk factors associated with post-operative ECMO support during LTx were identified. The relationship between primary graft dysfunction (PGD)/post-operative survival and duration of ECMO support was also analyzed. Results: Prolonged donor ventilation ≥ 5 days, pre-operative recipient mechanical ventilation, bilateral lung transplantation (BLT), veno-venous (V-V) ECMO and PGD in recipient were independent risk factors for post-operative ECMO support. The risk of PGD and post-operative death increased along with the increase of ECMO bypass time, and the mortality risk in group P was 2.33 (95% confidence interval: 1.16 - 4.67) times as that in group I. Conclusions: Mechanical ventilation for donor ≥ 5 days, pre-operative mechanical ventilation, BLT, V-V-ECMO and PGD in recipient were independent risk factors for post-operative ECMO support after LTx, and post-operative ECMO could not reduce recipients’ hospital mortality.
机译:背景:体外膜氧合(ECMO)是在肺移植(LTX)期间的心肺载体的有效佐剂治疗。然而,在LTX后与ECMO应用相关的因素仍然存在争议。本研究的目的是阐明术后ECMO支持的危险因素,并评估结果。方法:这是一家医院,单中心,回顾性研究。包括ECMO支持的LTX的266名患者。根据患者在手术后是否接受急性ECMO支持,已注册的患者进一步分为术中的ECMMO组(第I组,105例)和术后ECMO组(P组,161例)。收集捐助者和接受者的PERI操作数据。确定了与LTX后术后ECMO支持相关的独立风险因素。还分析了初级移植功能障碍(PGD)/术后存活和ECMO载体持续时间的关系。结果:延长供体通风≥5天,术前受体机械通风,双侧肺移植(BLT),静脉静脉(V-V)ECMO和PGD在受体中是术后ECMO支持的独立危险因素。随着ECMO旁路时间的增加,PGD和术后死亡的风险增加,P组的死亡率风险为2.33(95%置信区间:1.16-4.67)次,如第I次。结论:机械通气供体≥5天,接收者的术前机械通风,BLT,VV-ECMO和PGD是在LTX后术后ECMO支持的独立危险因素,并且操作后ECMO无法降低受体的医院死亡率。

著录项

  • 来源
    《外科学(英文)》 |2020年第008期|P.222-235|共14页
  • 作者单位

    Department of Anesthesiology The Third People’s Hospital of Shenzhen Shenzhen China;

    Department of Lung Transplantation Center The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi China;

    Department of Anesthesiology The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi China;

    Department of Anesthesiology The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi China;

    Department of Anesthesiology The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi China;

    Department of Lung Transplantation Center The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi China;

    Department of Anesthesiology The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi China;

    Department of Anesthesiology The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi China;

    Department of Lung Transplantation Center The Affiliated Wuxi People’s Hospital of Nanjing Medical University Wuxi China;

    Department of Anesthesiology The Third People’s Hospital of Shenzhen Shenzhen China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 chi
  • 中图分类 外科学各论;
  • 关键词

    Risk Factor; Extracorporeal Membrane Oxygenation; Lung Transplantation;

    机译:危险因素;体外膜氧合;肺移植;
  • 入库时间 2022-08-19 04:46:29
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号